Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.

Alcon

Status: Completed

Conditions: Dry Eye Symptoms; Visual Performance

Treatments: Other: Systane® Ultra

Study type: Interventional

Funder types: Industry

Identifiers

NCT00938951

SMA-09-22

Details and patient eligibility

About

The primary objective of this study is to compare visual degradation in a stressed (forced stare) environment in patients before and after acute administration of Systane Ultra.

Enrollment: 16 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Player/ Coach must answer "Yes" to the survey eligibility question.
• Player/Coach must voluntarily agree to participate in survey

Exclusion criteria

• None.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

16 participants in 1 patient group

Systane® Ultra

Experimental group

Description:

Systane® Ultra

Treatment:

Other: Systane® Ultra